Literature DB >> 15174227

Change in serum concentrations of interleukin-2 and interferon-gamma during treatment of tuberculosis.

M Berktas1, H Guducuoglu, H Bozkurt, K T Onbasi, M G Kurtoglu, S Andic.   

Abstract

We aimed to investigate changes in serum concentrations of the cytokines interleukin (IL)-2 and interferon (IFN)-gamma during the clinical course of active tuberculosis, to establish the presence of cellular immunity before and after treatment. Blood samples were taken from 18 patients with active tuberculosis before and 2 months after therapy; IL-2 and IFN-gamma concentrations were evaluated. The mean serum IL-2 concentration before therapy was 164.5 pg/ml (range 12-980 pg/ml) and the concentration 2 months after therapy was 92.11 pg/ml (range 1-490 pg/ml). The mean serum IFN-gamma concentrations were 10.83 pg/ml (range 1-22.2 pg/ml) and 4.64 pg/ml (range 1-28.5 pg/ml), respectively. The decrease in concentrations of both cytokines after therapy was statistically significant. Further studies investigating the benefits of adding cytokines to drug treatment for tuberculosis are needed.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15174227     DOI: 10.1177/147323000403200313

Source DB:  PubMed          Journal:  J Int Med Res        ISSN: 0300-0605            Impact factor:   1.671


  10 in total

1.  Plasma cytokine levels characterize disease pathogenesis and treatment response in tuberculosis patients.

Authors:  Monika M Vivekanandan; Ernest Adankwah; Wilfred Aniagyei; Isaac Acheampong; Augustine Yeboah; Joseph F Arthur; Millicent N K Lamptey; Mohammed K Abass; Amidu Gawusu; Francis Kumbel; Francis Osei-Yeboah; Linda Batsa Debrah; Dorcas O Owusu; Alexander Debrah; Ertan Mayatepek; Julia Seyfarth; Richard O Phillips; Marc Jacobsen
Journal:  Infection       Date:  2022-06-27       Impact factor: 3.553

2.  Context-dependent effects of IL-2 rewire immunity into distinct cellular circuits.

Authors:  Carly E Whyte; Kailash Singh; James Dooley; Oliver T Burton; Meryem Aloulou; Lubna Kouser; Rafael Valente Veiga; Amy Dashwood; Hanneke Okkenhaug; Samira Benadda; Alena Moudra; Orian Bricard; Stephanie Lienart; Pascal Bielefeld; Carlos P Roca; Francisco José Naranjo-Galindo; Félix Lombard-Vadnais; Steffie Junius; David Bending; Masahiro Ono; Tino Hochepied; Timotheus Y F Halim; Susan Schlenner; Sylvie Lesage; Adrian Liston
Journal:  J Exp Med       Date:  2022-06-14       Impact factor: 17.579

3.  Molecular signatures distinguishing active from latent tuberculosis in peripheral blood mononuclear cells, after in vitro antigenic stimulation with purified protein derivative of tuberculin (PPD) or Candida: a preliminary report.

Authors:  Joel N H Stern; Derin B Keskin; Viviana Romero; Joaquin Zuniga; Liliana Encinales; Changlin Li; Carlos Awad; Edmond J Yunis
Journal:  Immunol Res       Date:  2009       Impact factor: 2.829

4.  Is IP-10 an accurate marker for detecting M. tuberculosis-specific response in HIV-infected persons?

Authors:  Delia Goletti; Alamelu Raja; Basirudeen Syed Ahamed Kabeer; Camilla Rodrigues; Archana Sodha; Stefania Carrara; Guy Vernet; Christophe Longuet; Giuseppe Ippolito; Satheesh Thangaraj; Marc Leportier; Enrico Girardi; Philippe Henri Lagrange
Journal:  PLoS One       Date:  2010-09-07       Impact factor: 3.240

5.  IP-10 detection in urine is associated with lung diseases.

Authors:  Angela Cannas; Ludovica Calvo; Teresa Chiacchio; Gilda Cuzzi; Valentina Vanini; Francesco N Lauria; Luigia Pucci; Enrico Girardi; Delia Goletti
Journal:  BMC Infect Dis       Date:  2010-11-22       Impact factor: 3.090

6.  Changes in serum cytokine levels in active tuberculosis with treatment.

Authors:  Figen Deveci; H Handan Akbulut; Teyfik Turgut; M Hamdi Muz
Journal:  Mediators Inflamm       Date:  2005-10-24       Impact factor: 4.711

7.  Simple manual roller pump-driven valve-free microfluidic solution exchange system for urgent bioassay.

Authors:  Gokul Chandra Biswas; Hiroaki Suzuki
Journal:  RSC Adv       Date:  2022-01-21       Impact factor: 3.361

8.  Allergic sensitisation in tuberculosis patients at the time of diagnosis and following chemotherapy.

Authors:  Linda K Ellertsen; Dag G Storla; Lien M Diep; Karl A Brokstad; Harald G Wiker; Geir Hetland
Journal:  BMC Infect Dis       Date:  2009-06-26       Impact factor: 3.090

9.  Improving T-cell assays for the diagnosis of latent TB infection: potential of a diagnostic test based on IP-10.

Authors:  Morten Ruhwald; Janne Petersen; Kristian Kofoed; Hiroshi Nakaoka; Luis Eduardo Cuevas; Lovett Lawson; Stephen Bertil Squire; Jesper Eugen-Olsen; Pernille Ravn
Journal:  PLoS One       Date:  2008-08-06       Impact factor: 3.240

10.  Comparison of serum neopterin levels in pulmonary tuberculosis patients with positive acid fast bacilli and inactive pulmonary tuberculosis.

Authors:  Soedarsono Soedarsono; Parluhutan Dolli
Journal:  J Clin Tuberc Other Mycobact Dis       Date:  2019-12-04
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.